Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Reaches New 12-Month High at $4.40

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $4.40 and last traded at $4.28, with a volume of 794428 shares. The stock had previously closed at $4.28.

CVRS has been the topic of several analyst reports. Cowen lowered Corindus Vascular Robotics from an “outperform” rating to a “market perform” rating and upped their target price for the stock from $4.00 to $4.28 in a report on Thursday, August 8th. Zacks Investment Research lowered Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, August 13th.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings data on Thursday, August 8th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). The firm had revenue of $4.58 million during the quarter, compared to the consensus estimate of $4.10 million.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Jane Street Group LLC raised its holdings in shares of Corindus Vascular Robotics by 1,819.9% in the 2nd quarter. Jane Street Group LLC now owns 313,497 shares of the medical equipment provider’s stock valued at $934,000 after purchasing an additional 297,168 shares during the period. D. E. Shaw & Co. Inc. bought a new stake in shares of Corindus Vascular Robotics in the 2nd quarter valued at about $58,000. Cubist Systematic Strategies LLC bought a new stake in shares of Corindus Vascular Robotics in the 2nd quarter valued at about $97,000. Vanguard Group Inc. raised its holdings in shares of Corindus Vascular Robotics by 39.5% in the 2nd quarter. Vanguard Group Inc. now owns 5,286,173 shares of the medical equipment provider’s stock valued at $15,753,000 after purchasing an additional 1,496,809 shares during the period. Finally, A.R.T. Advisors LLC bought a new stake in shares of Corindus Vascular Robotics in the 2nd quarter valued at about $371,000.

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

Further Reading: Which market index is the best?

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.